Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Corn
North Carolina Agriculture & Technical State University · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT07767162
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 25–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 16
- US sites recruiting
- 1
- Study start
- August 4, 2026
- Record last updated
- August 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this research study is to identify biomarkers of whole grain (WG) corn intake following an acute exposure in a pharmacokinetic (how the body absorbs, processes, and gets rid of a substance or ingredient) feeding study. In this aim, investigators will conduct a randomized crossover acute pharmacokinetic study of corn. Investigators will then use a targeted metabolomics approach to identify the exposure markers of corn intake, further develop analytical methods to study its pharmacokinetics, and build our in-house WG metabolite database and an untargeted metabolomics approach to investigate postprandial biomarkers of corn intake. At the completion of this study, our expectation is that investigators will identify corn phytochemicals and its metabolites as objective biomarkers of total and individual WG corn that are commonly consumed by Americans.
Being studied: Whole-Grain Corn; Refined Corn
Conditions: Healthy Adult Females; Healthy Adult Males
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults aged 25-70 years
- Body mass index (BMI) between 18 and 30 kg/m²
- Able to read, speak, and understand English
- No known allergy or intolerance to the test foods
- Normal blood and urine biochemical parameters
- No antibiotic use within the past 6 months
- Willing and able to comply with all study procedures, including dietary restrictions throughout the study period
- No medical conditions or lifestyle factors that, in the opinion of the investigators, would interfere with the study objectives
Exclusion Criteria
- Active disease, including gout, heart disease, peripheral vascular disease, kidney disease, liver disease, cancer, diabetes, gastrointestinal disorders, or endocrine disorders that may interfere with the study
- Current smoker or use of tobacco products
- Unwilling or unable to comply with the required dietary restrictions during the study period
Recruiting US locations
Clinical Research Core (CRC)
Kannapolis, NC 28081
Site contact: Samantha Carroll · 704-250-5083 · crc_studies@unc.edu
Study contacts (from the official record)
- Shengmin Sang · 704-250-5710 · ssang@ncat.edu
Similar studies in North Carolina
All healthy volunteers studies in North Carolina →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Nalmefene Implant in Healthy Subjects
ReacX Pharmaceuticals, Inc.
- Location
- Morrisville, NC
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
University of North Carolina, Chapel Hill
- Location
- Chapel Hill, NC + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Breastfeeding Intervention to Prevent Obesity Among Children
University of North Carolina, Greensboro
- Location
- Greensboro, NC + 1 other US site
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Charlotte, NC + 7 other US sites
- Eligibility basics
- Ages 12–55